ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2012

Feb 22, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2012-02-16

Reporting Person: GIVEN DOUGLAS B (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option grant dated 02/16/12	$5.19	2022-02-16	Common Stock (30000)		Direct

Footnotes

F1: Option vests one year from date of grant.